Based on the key indicators obtained from Sotera Health's historical financial statements, Sotera Health Co is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in December. At present, Sotera Health's Other Liabilities is projected to decrease significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 100.1 M, whereas Total Current Liabilities is forecasted to decline to about 221.2 M. Key indicators impacting Sotera Health's financial strength include:
The essential information of the day-to-day investment outlook for Sotera Health includes many different criteria found on its balance sheet. An individual investor should monitor Sotera Health's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Sotera Health.
Net Income
53.94 Million
Sotera
Select Account or Indicator
Price To Sales Ratio
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Net Borrowings
Total Cashflows From Investing Activities
Other Cashflows From Financing Activities
Capital Expenditures
Total Cash From Operating Activities
Change To Operating Activities
Other Cashflows From Investing Activities
Change To Netincome
Change To Liabilities
Change To Inventory
Investments
Change In Cash
Depreciation
Change To Account Receivables
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Stock Based Compensation
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Non Cash Items
Sale Purchase Of Stock
Other Current Liab
Total Current Liabilities
Other Liab
Net Tangible Assets
Retained Earnings
Accounts Payable
Other Assets
Net Receivables
Other Current Assets
Other Stockholder Equity
Total Current Assets
Common Stock
Property Plant Equipment
Total Assets
Short Long Term Debt Total
Total Stockholder Equity
Property Plant And Equipment Net
Current Deferred Revenue
Net Debt
Cash
Non Current Assets Total
Non Currrent Assets Other
Long Term Debt
Cash And Short Term Investments
Good Will
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Non Current Liabilities Total
Capital Lease Obligations
Inventory
Total Liab
Net Invested Capital
Property Plant And Equipment Gross
Short Long Term Debt
Accumulated Other Comprehensive Income
Non Current Liabilities Other
Net Working Capital
Short Term Debt
Intangible Assets
Short Term Investments
Interest Expense
Net Income Applicable To Common Shares
Income Tax Expense
Minority Interest
Ebit
Tax Provision
Net Interest Income
Depreciation And Amortization
Selling General Administrative
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Net Income From Continuing Ops
Ebitda
Cost Of Revenue
Total Operating Expenses
Reconciled Depreciation
Income Before Tax
Total Other Income Expense Net
Probability Of Bankruptcy
Understanding current and past Sotera Health Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Sotera Health's financial statements are interrelated, with each one affecting the others. For example, an increase in Sotera Health's assets may result in an increase in income on the income statement.
Please note, the presentation of Sotera Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sotera Health's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Sotera Health's management manipulating its earnings.
Sotera Health Stock Summary
Sotera Health competes with Qiagen NV, Aclaris Therapeutics, Neogen, RadNet, and Myriad Genetics. Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio. Sotera Health operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 3000 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
Comparative valuation techniques use various fundamental indicators to help in determining Sotera Health's current stock value. Our valuation model uses many indicators to compare Sotera Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sotera Health competition to find correlations between indicators driving Sotera Health's intrinsic value. More Info.
Sotera Health Co is rated third in return on equity category among its peers. It is rated second in return on asset category among its peers reporting about 0.46 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Sotera Health Co is roughly 2.17 . At present, Sotera Health's Return On Equity is projected to increase slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sotera Health's earnings, one of the primary drivers of an investment's value.
Sotera Health Systematic Risk
Sotera Health's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Sotera Health volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Sotera Health correlated with the market. If Beta is less than 0 Sotera Health generally moves in the opposite direction as compared to the market. If Sotera Health Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Sotera Health is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Sotera Health is generally in the same direction as the market. If Beta > 1 Sotera Health moves generally in the same direction as, but more than the movement of the benchmark.
Sotera Health Thematic Clasifications
Sotera Health Co is part of Healthcare investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Healthcare industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Today, most investors in Sotera Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Sotera Health's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Sotera Health growth as a starting point in their analysis.
Price Earnings To Growth Ratio
(0.8)
At present, Sotera Health's Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting.
Sotera Health November 28, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Sotera Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Sotera Health Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sotera Health Co based on widely used predictive technical indicators. In general, we focus on analyzing Sotera Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sotera Health's daily price indicators and compare them against related drivers.
When running Sotera Health's price analysis, check to measure Sotera Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sotera Health is operating at the current time. Most of Sotera Health's value examination focuses on studying past and present price action to predict the probability of Sotera Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sotera Health's price. Additionally, you may evaluate how the addition of Sotera Health to your portfolios can decrease your overall portfolio volatility.